A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome

American Journal of Ophthalmology

Volumn 138, Issue 1, 2004, Pages 18-32

  Vitale, Susan ^a,b   Miller, Neil R ^a   Mejico, Luis J ^a   Perry, Julian D ^a   Medura, Marianne ^a   Freitag, Suzanne K ^a   Girkin, Christopher ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PLANT EXTRACT; SUPER BLUE GREEN ALGAE EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLEPHAROSPASM; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; EYELID REFLEX; FEMALE; HUMAN; IMMOBILIZATION; INJECTION; MALE; MEDICAL DOCUMENTATION; MEIGE DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SUPPLEMENTATION; VIDEORECORDING;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BLEPHAROSPASM; BLINKING; BOTULINUM TOXIN TYPE A; CROSS-OVER STUDIES; CYANOBACTERIA; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MEIGE SYNDROME; MIDDLE AGED; MUSCLE RELAXATION; NEUROMUSCULAR AGENTS; TREATMENT OUTCOME;

EID: 3042796459     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2004.02.062     Document Type: Article

References (16)

1. Patel B.C.K., Anderson R.L. Blepharospasm and related facial movement disorders. Curr Opin Ophthalmol. 6:1995;86-89
2. Hallett M. Blepharospasm. Recent advances. Neurology. 59:2002;1306-1312
3. Information about super blue-green algae. Available at: http://www.protector.pair.com/ms/superalgea.html. Accessed October 2003
4. What are present "algae consumers" saying about their experiences? Available at: http://www.websites.celltech.com/sbgalgae01/files/ testimonial.htm. Accessed October 2003
5. Benefits you may experience from super blue green nutritional supplements. Available at: http://www.websites.celltech.com/sbgalgae01/files/ benefits.htm. Accessed October2003
6. Bhat V.B., Madyastha K.M. C-phycocyanin a potent peroxyl radical scavenger in vivo and in vitro. Biochem Biophys Res Commun. 275:2000;20-25
7. Hayashi K., Hayashi T., Kojima I. A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis in vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities. AIDS Res Hum Retroviruses. 12:1996;1463-1471
8. Qureshi M., Garlich J., Kidd M.T. Dietary Spirulina platensis enhances humoral and cell-mediated immune function in chickens. Immunopharmacol Immunotoxicol. 18:1996;465-476
9. Boyd M.R., Gustafson K.R., McMahon J.B., et al. Discovery of cyanovirin-N, a novel human immunodeficiency virusinactivating protein that binds viral surface envelope glycoprotein gp120 potential applications to microbiocide development. Antimicrob Agents Chemother. 41:1997;1521-1530
10. Schaeffer D.J., Krylov V.S. Anti-HIV activity of extracts and compounds from algae and cyanobacteria (review). Ecotoxicol Env Safety. 45:2000;208-227
11. Lindeboom R., De Haan R., Aramideh M., Speelman J.D. The blepharospasm disability scale an instrument for the assessment of functional health in blepharospasm. Mov Disord. 10:1995;444-449
12. Senn S. Crossover trials in clinical research. 1993;John Wiley & Sons
13. Armitage P., Berry G. Statistical methods in medical research. 3rd ed:1994;Blackwell Scientific, Oxford. 453-458
14. McCullagh P., Nelder J.A. Generalized linear models. 2nd ed. Monographs on statistics and applied probability. 1989;Chapman & Hall, London
15. Mauriello J.A. Jr. Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years. Br J Ophthalmol. 80:1996;1073-1076
16. Drummond G.T., Hinz B.J. Botulinum toxin for blepharospasm and hemifacial spasm stability of duration of effect and dosage over time. Can J Ophthalmol. 36:2001;398-403